STZ

Business Profile & Competitive Position

Constellation Brands, Inc. (STZ) fits squarely in the Consumer Defensive sector and the Beverages - Alcoholic industry. Its core business is importing, producing, and marketing alcoholic beverages, with a heavy emphasis on the U.S. beer market. Because the data does not break out brand-level revenue, the safest way to assess its competitive position is through reported profitability. The company posted a 20.1% net margin and a 23.1% return on equity. Those figures imply that roughly one in five dollars of revenue reaches the bottom line, and the business earns more than twenty cents of net profit for every dollar of shareholders’ equity. In a mature consumer-staples category, an ROE above 20% is generally consistent with durable pricing power and scale advantages in marketing, distribution, or procurement. The beta of 0.38 sits well below market average, reflecting the relatively stable demand typical for alcoholic beverages. Together, the margin and ROE suggest that STZ is not a price-taker; rather, it appears to command enough brand equity and shelf access to sustain above-average economics.

Financial Posture

As of the latest snapshot, Constellation Brands carried a market capitalization of $23.2 billion and traded at a trailing P/E of 12.9. Against that, the 20.1% net margin and 23.1% ROE frame the valuation as undemanding relative to the company’s profitability profile. A P/E below 13 combined with returns on equity above 20% is unusual outside of sectors where growth is perceived as constrained or balance-sheet risk is elevated, so the next layer of any analysis should focus on leverage, free-cash-flow conversion, and growth in depletions and pricing. The stock’s current price of $135.76 sits just under the 50-day exponential moving average of $136.64, while the RSI at 55.0 is neutral. The 0.38 beta reinforces the low-volatility, defensive characterization. No debt figure is provided in this dataset, so no leverage conclusion can be drawn here; an investor would need to verify total debt, interest coverage, and corporate-bond ratings separately.

Macro & Geopolitical Exposure

By classification, STZ is exposed to the standard macro and geopolitical risks of the alcoholic-beverage industry. Regulation is a structural factor: excise taxes, labeling requirements, advertising restrictions, and three-tier distribution laws in the United States can all affect costs and pricing power. Trade policy matters because imported beer and spirits, as well as inputs such as aluminum, glass, barley, and grapes, cross borders; tariffs or currency swings involving the Mexican peso or euro can move costs and reported margins. Commodity-price volatility in packaging materials and agricultural inputs feeds directly into gross margin. Currency exposure is real for any business that sources or prices goods internationally. On the demand side, alcoholic beverages are considered defensive, but premiumization trends can still shift with disposable income, unemployment, and consumer confidence. Interest rates matter less to the end consumer than to corporate refinancing and distribution financing, but a low-beta profile like STZ’s 0.38 does not eliminate that sensitivity entirely.

Recent Developments

Four recent headlines capture the immediate narrative around the stock. On July 30, 2026, zacks.com asked why Constellation Brands was “Down 3.8% Since Last Earnings Report” and whether it could rebound. That headline lines up with the June 30, 2026 quarter, in which STZ beat EPS expectations yet the stock fell 1.59% the next day and 6.29% over the following five sessions. On July 27, 2026, defenseworld.net reported two institutional moves: Entropy Technologies LP held $2.35 million in STZ stock, while Arrowstreet Capital Limited Partnership sold 778,526 shares. The same institution in both directions buying and selling within a single day highlights mixed institutional sentiment rather than a one-way flow. On July 23, 2026, marketbeat.com reported that shareholders approved directors, the executive pay plan, and the incentive plan at the annual meeting. That is routine governance progress, but it matters because compensation votes can signal whether investors are comfortable with management’s capital-allocation incentives.

Earnings Behavior & Post-Earnings Drift

Over the last eight reported quarters, Constellation Brands beat earnings expectations six times, a 75% beat rate, with an average EPS surprise of 7.3%. Across those quarters, the average five-day post-earnings price move was 4.02% and classified as upward drift. Those headline figures alone do not tell the full story. The most recent four quarters show a clear disconnect between “beating estimates” and “post-earnings follow-through.” On June 30, 2026, STZ reported actual EPS of $3.43 against an estimate of $3.22, a 6.5% beat, but the stock fell 1.59% the next day and 6.29% over the next five trading days. By contrast, on April 8, 2026, actual EPS of $1.90 beat the $1.71 estimate by 11.1%, and the stock jumped 8.53% the next day and 9.11% over five days. On January 7, 2026, actual EPS of $3.06 beat the $2.63 estimate by 16.3%, producing a 5.32% one-day gain and an 11.3% five-day gain. Going back to October 6, 2025, actual EPS of $3.63 beat the $3.38 estimate by 7.4%, but the move was only 1.03% the next day and 1.97% over the next five sessions.

The average five-day drift is positive only because the large April and January gains outweigh the June selloff. That pattern is the key insight for STZ: even when the official consensus is beaten, the stock does not reliably continue in the direction of the surprise. A beat can be met with selling if guidance, margin commentary, or broader sector flows disappoint, while a modest beat can produce outsized rallies when setup and sentiment align. The next scheduled report is October 5, 2026, after the close, with a consensus EPS estimate of $3.63. At a current RSI of 55.0 and a price essentially at the 50-day EMA, technical setup going into that report looks neutral rather than stretched.

For a deeper dive, you should review the full institutional verdict surrounding STZ—covering how buy-side positioning, analyst model revisions, and forward guidance are stacking up against the company’s 20.1% net margin and 23.1% ROE—rather than relying on any single headline or quarter.